China Resources Boya Bio pharmaceutical Group Co Ltd SZSE:300294:
9M NET PROFIT FOR CR BOYA BIO-PHARMACEUTICAL RMB343 MILLION
9M CR BOYA BIO-PHARMACEUTICAL REVENUE RMB1.47 BILLION
China Resources Pharmaceutical Says 9M Net Profit For CR Boya Bio-Pharmaceutical At RMB343 Million
Earlier from China Resources Boya Bio-pharmaceutical Group Co., Ltd. Class A
- China Resources Boya Bio-pharmaceutical Group: Revenue up, profit down YTD, cash flow pressured, Boya Xinhe deconsolidated
- China Resources Boya Bio-pharmaceutical Group: Revenue up 12.5% but net profit down 28.7% amid margin and policy pressures
- China Resources Boya Bio-pharmaceutical Group: Revenue up 19.49% but net profit down 8.25% as costs rise and cash flow turns negative
- China Resources Boya Bio-pharmaceutical Group: Net profit jumped 67% to ¥397M as core blood products outperformed despite revenue decline